Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Cumberland Pharmaceuticals Inc. (CPIX) had Return on Tangible Equity of -37.12% for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
$9.09M |
|
$-1.54M |
|
$1.32M |
|
$7.76M |
|
$10.78M |
|
$-1.69M |
|
$0.17M |
|
$-1.53M |
|
$-1.53M |
|
$-1.54M |
|
$-1.54M |
|
$-1.54M |
|
$-1.54M |
|
$-1.69M |
|
$-0.58M |
|
14.05M |
|
14.05M |
|
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
$35.24M |
|
$0.31M |
|
$41.51M |
|
$76.75M |
|
$31.09M |
|
$10.10M |
|
$21.19M |
|
$52.28M |
|
$24.47M |
|
$4.14M |
|
$24.47M |
|
14.01M |
|
| Cash Flow Statement Financials | |
$-2.52M |
|
$0.08M |
|
$1.58M |
|
$18.32M |
|
$17.46M |
|
$-0.86M |
|
$0.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.13 |
|
-- |
|
-- |
|
0.29 |
|
0.66 |
|
85.44% |
|
-18.65% |
|
-18.65% |
|
-- |
|
-16.79% |
|
-16.99% |
|
$-2.58M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.29 |
|
0.80 |
|
112.04 |
|
-6.28% |
|
|
Return on Tangible Equity |
-37.12% |
-2.00% |
|
-4.45% |
|
$1.75 |
|
$-0.18 |
|
$-0.18 |
|